Form 4: Aveanna Healthcare Holdings: J.H. Whitney Affiliates Execute Stock Sales Under 10b5-1 Plan
SEC Form 4
Paul R. Vigano, on behalf of J.H. Whitney-affiliated entities, reports the sale of Aveanna Healthcare Holdings (AVAH) common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Paul R. Vigano, acting on behalf of several J.H. Whitney-affiliated entities, filed a Form 4 detailing the sale of Aveanna Healthcare Holdings, Inc. (AVAH) common stock.
- The sales were executed on March 18 and 19, 2025, under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024.
- The entities involved include J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
- The sales occurred at weighted average prices of $5.51 and $5.46 per share on March 18 and 19, 2025, respectively.
- The total number of shares sold by these entities was approximately 149,491.
- Following the reported transactions, the J.H. Whitney-affiliated entities continue to hold significant indirect beneficial ownership of Aveanna Healthcare Holdings common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports stock sales under a pre-arranged trading plan, without providing any explicit positive or negative commentary on the company's performance or outlook.
Future Outlook
The document does not contain any specific forward-looking statements regarding Aveanna Healthcare Holdings' future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell the company's stock; in this case, the sales were executed under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.
Stakeholder Impact
- The stock sales by J.H. Whitney-affiliated entities could potentially exert downward pressure on Aveanna Healthcare Holdings' stock price in the short term.
- However, the existence of a pre-arranged trading plan suggests that these sales are part of a long-term strategy and may not reflect a fundamental change in the entities' view of the company's value.
Key Dates
| Date | Description |
|---|---|
| 12/13/2024 | Date of adoption of the Rule 10b5-1 trading plan by the Stockholder Entities |
| 03/18/2025 | Date of first reported transaction (stock sale) at a weighted average price of $5.51 |
| 03/19/2025 | Date of second reported transaction (stock sale) at a weighted average price of $5.46 |
| 03/20/2025 | Date of signature on the Form 4 filing by Paul R. Vigano |
Keywords
Aveanna Healthcare Holdings, AVAH, J.H. Whitney, Paul R. Vigano, Form 4, Rule 10b5-1, Stock Sale, Beneficial Ownership, Securities, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.